Impact of primordial magnetic fields on the first-order electroweak phase transition
Physical Review D · 20.02.2026 · 113 (4)
DOI: 10.1103/jrd3-s1h2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review D, online erschienen am 20.02.2026. Verfasst von Yuefeng Di und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, “Young Talents” Project of Northeast Agricultural University.
Abstract (Originalsprache)
We numerically study how the primordial magnetic field affects the first-order electroweak phase transition in the early Universe. We observe the following: 1) the phase transition process would be slowed down by the magnetic field; 2) the phenomenon of vortex structure of the Higgs condensation appears when the homogenesis hypermagentic field g ′ B Y e x / m W 2 ≳ 3.63 ; and, 3) the helical hypermagnetic field can dramatically enhance the sphaleron rate and validate the generation of the baryon asymmetry through the chiral anomaly.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- “Young Talents” Project of Northeast Agricultural University
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Di, Y., Bian, L., & Cai, R. (2026). Impact of primordial magnetic fields on the first-order electroweak phase transition. Physical Review D, 113(4). https://doi.org/10.1103/jrd3-s1h2
Vancouver
Di Y, Bian L, Cai R. Impact of primordial magnetic fields on the first-order electroweak phase transition. Physical Review D. 2026;113(4). doi:10.1103/jrd3-s1h2
BibTeX
@article{Di2026,
author = {Di, Yuefeng and Bian, Ligong and Cai, Rong-Gen},
title = {Impact of primordial magnetic fields on the first-order electroweak phase transition},
journal = {Physical Review D},
year = {2026},
volume = {113},
number = {4},
doi = {10.1103/jrd3-s1h2}
}
EUVIMED